Novartis loses patent appeal in landmark suit
Supreme Court upholds amended law that bars patents for insignificant improvements to an existing drug—in this case anti-cancer drug …
Gopal Subramaniam, Rohinton Nariman swap places in Novartis patent case
Will take on each other in the patent case of anti-cancer drug Glivec filed by Novartis
Why scientists don’t back Novartis claim
As Novartis’ Indian patent case reaches end, a reminder of how scientists view unfair patents
India’s 3 D Message
The Supreme Court judgment in the Novartis case clearly upholds India’s patent laws, not weakens the patent regime
Evergreen Novartis
The Swiss pharma giant’s challenge to India’s patent law, now in the Supreme Court, may help define drug efficacy
Drug affordability test
Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ …
